Home » Management of the Patient Undergoing Radiotherapy or Chemotherapy
REFERENCES
1. Grisius M: Salivary gland dysfunction: a review of systemic
therapies, Oral Surg Oral Med Oral PathoI92:1S6, 2001.
2. Khan Z,Jacobsen CS:Oral pilocarpine HCI’fOl:post-irradiation
xerostomia in head and neck cancer patients. In Proceedings
of the First International Congress on Max.illof(l~ial Prosthetics,
New York, 1995, Memorial Sloan-Kettering Cancer
Center.
41 6 PART IV • Infections
3. 5pij
DENTAL MANAGEMENT OF PATIENTS ON SYSTEMIC CHEMOTHERAPY FOR MALIGNANT OISEASE
Destruction of malignant cells by tumoricidal chemotherapeutic drugs has proved an effective treatment for a variety of malignancies. Like radidtherapy, the antitumor effectof cancer chemotherapeutic agents is based on their ability to destroy or retard the division of rapidly proliferating
cells, such as tumor cells, nonspeclfically
DENTAL MANAGEMENT OF PATIENTS UNDERGOING RADIOTHERAPY TO HEAD AND NECk
Radiotherapy (i.e., radiation therapy, x-ray treatment) is a common therapeutic modality for malignancies of the head and neck. Approximately 30,000 cases of ‘head and neck cancer occur each year. Many of these are managed by therapeutic irradiation. Its’ use is ideally predicated on the abilitv of the radiation to destroy neo
CHAPTER OUTLINE
DENTAL MANACEMENT OF PATIENTS UNDERGOING
RADIOTHERAPY TO HEAD AND NECK
Radiation Effects on Oral Mucosa
Radiation Effects on Salivary Glands
Treatment of Xerostomia
Radiation Effects on Bone
Other Effects of Radiation
Evaluation of Dentition Before Radiotherapy
Condition of Residual Dentition
Patient’s Dental Awareness
Immediacy of Radiotherapy
Radiation Location
Radiation Dose
Preparation of
